Improved survival with higher doses of octreotide long-acting release in gastroenteropancreatic neuroendocrine tumors
出版年份 2018 全文链接
标题
Improved survival with higher doses of octreotide long-acting release in gastroenteropancreatic neuroendocrine tumors
作者
关键词
Neuroendocrine tumor, Carcinoid tumor, Carcinoid syndrome, Somatostatin, Octreotide
出版物
MEDICAL ONCOLOGY
Volume 35, Issue 9, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-04
DOI
10.1007/s12032-018-1189-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
- (2017) Daniel M Halperin et al. LANCET ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors
- (2016) Chan Shen et al. ONCOLOGIST
- Carcinoid and Neuroendocrine Tumors: Building on Success
- (2015) Pamela L. Kunz JOURNAL OF CLINICAL ONCOLOGY
- Neuroendocrine Tumors, Version 1.2015
- (2015) Matthew H. Kulke et al. Journal of the National Comprehensive Cancer Network
- Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review
- (2015) Michael S Broder WORLD JOURNAL OF GASTROENTEROLOGY
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
- (2015) Khalid Al-Efraij et al. Cancer Medicine
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study
- (2014) J. R. Strosberg et al. ONCOLOGIST
- Impact of Octreotide Long-Acting Release on Tumour Growth Control as a First-Line Treatment in Neuroendocrine Tumours of Pancreatic Origin
- (2013) H. Jann et al. NEUROENDOCRINOLOGY
- Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
- (2011) William H. Ludlam et al. ADVANCES IN THERAPY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period
- (2011) Lowell Anthony et al. PANCREAS
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More